These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

769 related items for PubMed ID: 33861727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A, Foo HJL, Lim JKW, Chander RJ, Yong TT, Ng ASL, Hameed S, Ting SKS, Zhou J, Kandiah N.
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [Abstract] [Full Text] [Related]

  • 3. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A, Kumar D, Soo SA, Zailan FZ, Leow YJ, Koh CL, Ng ASL, Ng KP, Kandiah N.
    Alzheimers Res Ther; 2023 Jun 03; 15(1):103. PubMed ID: 37270543
    [Abstract] [Full Text] [Related]

  • 4. Differentiation of Early Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Healthy Elderly Samples Using Multimodal Neuroimaging Indices.
    Joshi H, Bharath S, Balachandar R, Sadanand S, Vishwakarma HV, Aiyappan S, Saini J, Kumar KJ, John JP, Varghese M.
    Brain Connect; 2019 Nov 03; 9(9):730-741. PubMed ID: 31389245
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Correspondence between white matter hyperintensities and regional grey matter volumes in Alzheimer's disease.
    Yi F, Wang J, Lin M, Li B, Han S, Wang S, Jin Y, Hu N, Chen Y, Shang X.
    Front Aging Neurosci; 2024 Nov 03; 16():1429098. PubMed ID: 39351014
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants.
    Brugulat-Serrat A, Salvadó G, Operto G, Cacciaglia R, Sudre CH, Grau-Rivera O, Suárez-Calvet M, Falcon C, Sánchez-Benavides G, Gramunt N, Minguillon C, Fauria K, Barkhof F, Molinuevo JL, Gispert JD, ALFA Study.
    Hum Brain Mapp; 2020 Apr 01; 41(5):1309-1322. PubMed ID: 31778002
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S, Lipton RB, Harvey DJ, Zammit AR, Ezzati A, Alzheimer's Disease Neuroimaging Initiative.
    J Am Geriatr Soc; 2021 Jul 01; 69(7):1906-1915. PubMed ID: 33891712
    [Abstract] [Full Text] [Related]

  • 13. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH, Bocchetta M, Heller C, Convery R, Neason M, Moore KM, Cash DM, Thomas DL, Woollacott IOC, Foiani M, Heslegrave A, Shafei R, Greaves C, van Swieten J, Moreno F, Sanchez-Valle R, Borroni B, Laforce R, Masellis M, Tartaglia MC, Graff C, Galimberti D, Rowe JB, Finger E, Synofzik M, Vandenberghe R, de Mendonça A, Tagliavini F, Santana I, Ducharme S, Butler C, Gerhard A, Levin J, Danek A, Frisoni GB, Sorbi S, Otto M, Zetterberg H, Ourselin S, Cardoso MJ, Rohrer JD, On behalf of, GENFI.
    Neuroimage Clin; 2019 Jul 01; 24():102077. PubMed ID: 31835286
    [Abstract] [Full Text] [Related]

  • 14. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K, Yamashita F, Tsugawa A, Haime R, Fukasawa R, Sato T, Kanetaka H, Umahara T, Sakurai H, Hanyu H, Shimizu S.
    J Alzheimers Dis; 2021 Jul 01; 80(2):877-883. PubMed ID: 33579856
    [Abstract] [Full Text] [Related]

  • 15. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A, Pettigrew C, Zhu Y, Wang MC, Moghekar A, Gottesman RF, Singh B, Martinez O, Fletcher E, DeCarli C, Albert M, BIOCARD Research Team.
    Neurology; 2020 Mar 03; 94(9):e950-e960. PubMed ID: 31888969
    [Abstract] [Full Text] [Related]

  • 16. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G, Mouiha A, Duchesne S, Bocti C, Alzheimer's Disease Neuroimaging Initiative1.
    J Alzheimers Dis; 2015 Mar 03; 46(4):855-62. PubMed ID: 26402625
    [Abstract] [Full Text] [Related]

  • 17. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
    Kamal F, Morrison C, Maranzano J, Zeighami Y, Dadar M.
    Geroscience; 2023 Feb 03; 45(1):1-16. PubMed ID: 36229760
    [Abstract] [Full Text] [Related]

  • 18. Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment.
    Zhu W, Huang H, Yang S, Luo X, Zhu W, Xu S, Meng Q, Zuo C, Liu Y, Wang W, Alzheimer’s Disease Neuroimaging Initiative.
    Neurosci Bull; 2021 Jun 03; 37(6):789-803. PubMed ID: 33826095
    [Abstract] [Full Text] [Related]

  • 19. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
    Kumar D, Vipin A, Wong B, Ng KP, Kandiah N.
    Brain Connect; 2020 Dec 03; 10(10):547-554. PubMed ID: 33050714
    [Abstract] [Full Text] [Related]

  • 20. Magnitude and kinetics of a set of neuroanatomic volume and thickness together with white matter hyperintensity is definitive of cognitive status and brain age.
    Yadav N, Gupta NK, Thakar D, Tiwari V.
    Transl Psychiatry; 2024 Sep 27; 14(1):389. PubMed ID: 39333492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.